Cardioplexol® was developed by Swiss Cardio Technologies AG, a private Swiss-based company.  
• Developed at the University Hospital of Berne, Switzerland (Inselspital) 
• Patent protection in all major markets worldwide

Cardioplexol® is marketed by:
MIT Gesundheit GmbH, Thaerstrasse 4A, 47533 Kleve, Germany (Europe)
Medius AG, Neue Bahnhofstrasse 160, 4132 Muttenz (Switzerland)